Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 34% ± 10% | |
peripheral blood | 18 studies | 41% ± 15% | |
brain | 16 studies | 42% ± 21% | |
intestine | 11 studies | 31% ± 11% | |
eye | 9 studies | 33% ± 17% | |
kidney | 8 studies | 30% ± 10% | |
heart | 5 studies | 35% ± 5% | |
lymph node | 5 studies | 39% ± 10% | |
breast | 5 studies | 36% ± 16% | |
liver | 5 studies | 51% ± 18% | |
bone marrow | 4 studies | 27% ± 9% | |
uterus | 4 studies | 44% ± 8% | |
skin | 4 studies | 33% ± 6% | |
prostate | 4 studies | 28% ± 4% | |
adipose | 4 studies | 52% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 11803.70 | 245 / 245 | 99% | 41.72 | 499 / 502 |
uterus | 100% | 9358.88 | 170 / 170 | 99% | 30.80 | 455 / 459 |
thymus | 100% | 15533.43 | 653 / 653 | 99% | 40.17 | 599 / 605 |
esophagus | 100% | 7680.04 | 1444 / 1445 | 99% | 19.74 | 181 / 183 |
bladder | 100% | 8170.19 | 21 / 21 | 99% | 27.86 | 498 / 504 |
ovary | 100% | 9344.85 | 180 / 180 | 98% | 26.30 | 423 / 430 |
intestine | 100% | 10481.81 | 966 / 966 | 98% | 23.62 | 515 / 527 |
brain | 99% | 6843.37 | 2608 / 2642 | 99% | 25.70 | 698 / 705 |
breast | 100% | 8766.86 | 459 / 459 | 98% | 20.60 | 1091 / 1118 |
adrenal gland | 100% | 8514.12 | 258 / 258 | 97% | 17.40 | 224 / 230 |
pancreas | 99% | 4814.44 | 324 / 328 | 98% | 30.34 | 175 / 178 |
lung | 100% | 11502.79 | 578 / 578 | 96% | 22.57 | 1106 / 1155 |
stomach | 100% | 7457.43 | 358 / 359 | 95% | 19.68 | 273 / 286 |
kidney | 100% | 9745.66 | 89 / 89 | 91% | 23.17 | 820 / 901 |
skin | 100% | 6994.76 | 1807 / 1809 | 86% | 18.33 | 406 / 472 |
liver | 97% | 5706.69 | 220 / 226 | 84% | 10.91 | 340 / 406 |
spleen | 100% | 16624.02 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.55 | 1 / 1 |
blood vessel | 100% | 9059.43 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 7893.64 | 1199 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 5023.99 | 848 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 36.92 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 93% | 20.55 | 42 / 45 |
peripheral blood | 90% | 6150.73 | 832 / 929 | 0% | 0 | 0 / 0 |
muscle | 84% | 2589.55 | 671 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 10.49 | 48 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000245 | Biological process | spliceosomal complex assembly |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | RSRP1 |
Protein name | Arginine/serine-rich protein 1 |
Synonyms | C1orf63 NPD014 HT033 |
Description | FUNCTION: Probably acts as a spliceosomal factor that contributes to spliceosome assembly and regulates the isoform switching of proteins such as PARP6. . FUNCTION: Probably acts as a spliceosomal factor that contributes to spliceosome assembly and regulates the isoform switching of proteins such as PARP6. . FUNCTION: Probably acts as a spliceosomal factor that contributes to spliceosome assembly and regulates the isoform switching of proteins such as PARP6. . FUNCTION: Probably acts as a spliceosomal factor that contributes to spliceosome assembly and regulates the isoform switching of proteins such as PARP6. . FUNCTION: Probably acts as a spliceosomal factor that contributes to spliceosome assembly and regulates the isoform switching of proteins such as PARP6. . FUNCTION: Probably acts as a spliceosomal factor that contributes to spliceosome assembly and regulates the isoform switching of proteins such as PARP6. . FUNCTION: Probably acts as a spliceosomal factor that contributes to spliceosome assembly and regulates the isoform switching of proteins such as PARP6. . |
Accessions | ENST00000568254.5 ENST00000565733.5 ENST00000243189.12 [Q9BUV0-1] ENST00000566395.5 H3BTJ0 H3BP33 H3BT33 H3BMX3 H3BMN1 ENST00000568996.1 ENST00000561867.1 Q9BUV0 ENST00000473314.6 [Q9BUV0-3] ENST00000568701.1 H3BVB7 ENST00000431849.3 [Q9BUV0-2] |